Stay updated on IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.

Latest updates to the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page
- Check2 days agoChange DetectedAdded a new revision entry 'Revision: v3.7.0' to the history, representing updated information being posted. The older revision 'Revision: v3.6.6' was removed from the history, altering the set of recorded revisions.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNew revision v3.6.6 is added to the history, replacing the previous v3.6.5 entry. This reflects an update to the record's version without altering the underlying study data or public-facing content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe page’s revision label updated from v3.6.4 to v3.6.5, indicating a new platform version. No changes to study content or metadata are indicated by this update.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision entry v3.6.4 was added to the record history, replacing the previous v3.6.3. This indicates an update to the study record’s versioning details rather than changes to the study content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.3, indicating a new release state of the study record. This reflects an internal update to the record history display rather than changes to the study content.SummaryDifference0.1%

- Check94 days agoChange DetectedThe record history shows recruitment is closed to new participants, and the history reflects a new revision tag (v3.6.0) while the previous revision tag (v3.5.5) was removed.SummaryDifference0.3%

Stay in the know with updates to IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.